Hypermenorrhea in the young hemodialysis patient.
D000293:Adolescent; D000328:Adult; D002587:Cesium Isotopes / Q000627:therapeutic use; D003036:Cobalt Isotopes / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000627:therapeutic use; D003475:Curettage; D004106:Dilatation; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008599:Menstruation Disturbances / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D008875:Middle Aged; D009584:Nitrogen / Q000097:blood; D011374:Progesterone / Q000627:therapeutic use; D006435:Renal Dialysis; D011795:Surveys and Questionnaires; D014511:Uremia / Q000150:complications
D002587:Cesium Isotopes; D003036:Cobalt Isotopes; D003276:Contraceptives, Oral; D004967:Estrogens; D011374:Progesterone; D009584:Nitrogen